Upgrade to SI Premium - Free Trial

Xenetic Biosciences (XBIO)

1.90 -0.12 (5.94%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

Xenetic Biosciences doses first patient in DNase and CAR T-cell study October 15, 2026 8:46 AM - StreetInsider Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells f October 15, 2026 8:46 AM - StreetInsider Form 8-K Xenetic Biosciences, For: Sep 23 September 23, 2026 5:21 PM - SEC Filing Form SCHEDULE 13G Xenetic Biosciences, Filed by: MJL Manager LLC September 18, 2026 2:36 PM - SEC Filing Xenetic Biosciences to acquire Santersus AG in all-stock deal September 16, 2026 7:01 AM - StreetInsider Form 8-K Xenetic Biosciences, For: Sep 14 September 16, 2026 7:01 AM - SEC Filing Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics September 16, 2026 7:00 AM - StreetInsider Form 8-K Xenetic Biosciences, For: Aug 07 August 7, 2026 8:35 AM - SEC Filing Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform August 7, 2026 8:35 AM - StreetInsider Form 10-Q Xenetic Biosciences, For: Jun 30 August 6, 2026 4:36 PM - SEC Filing Full Article List